Home
½ÃÀÛÆäÀÌÁö
Áö³È£º¸±â
·Î±×ÀÎ
ȸ¿ø°¡ÀÔ
±¸µ¶½Åû
Àüü±â»ç
2024-03-29 ±Ý 03:00
±â»ç°Ë»ö
Cover Story
¼øȯ±â
³»ºÐºñ
È£Èí±â
¼Òȱâ
½Å°æ°ú
Á¤½Å°Ç°
°¨¿°³»°ú
Sub Story
Interview
Drug Review
Conference Report
Late Breaking Studies
Expert Opinion
Primary Expert Opinion
The Rare Disease
ÇмúÀÚ¹®À§¿ø
RTM
»ó´Ü¿©¹é
񃯇
(Àüü 104°Ç)
Á¦¸ñº¸±â
Á¦¸ñº¸±â
Á¦¸ñ+³»¿ë
[Sub Story]
FAST¡¤FANTASTIC Çѱ¹ÀÎ Àӻ󿬱¸ ÁÖ¸ñ
ÀÌ»óµ· ±âÀÚ
2021-05-11 15:17
[Sub Story]
RAS¾ïÁ¦Á¦+ÀÌ´¢Á¦ º´¿ë¡¤º¹ÇÕÁ¦
ÀÌ»óµ· ±âÀÚ
2021-05-11 14:58
[Deep in Guideline]
MET + SGLT-2i 1Â÷ Ä¡·áÀü·«À¸·Î Á¦½Ã
ÀÓ¼¼Çü ±âÀÚ
2021-04-16 17:54
[Interview]
¡°½ÉºÎÀü °ü¸®¿¡¼ SGLT-2¾ïÁ¦Á¦ ¿ªÇÒ Ä¿Áú °Í¡±
ÀÓ¼¼Çü ±âÀÚ
2021-04-16 17:52
[Sub Story]
CKD + °íÇ÷¾Ð SBP 120mmHg ¹Ì¸¸À¸·Î
ÀÓ¼¼Çü ±âÀÚ
2021-04-16 17:52
¶óÀÎ
[Cover Story]
Ç÷¾Ð¡¤Ç÷´çÁ¶Àý ±âÀüÀ¸·Î ½ÉÀ塤½ÅÀåÁúȯ º® Çã¹®´Ù
ÀÌ»óµ· ±âÀÚ
2021-04-16 17:51
[Sub Story]
±¹³» CKD ȯÀÚ 460¸¸¸í ¿¬Æò±Õ 8.7% Áõ°¡ Áß
ÀÓ¼¼Çü ±âÀÚ
2021-04-16 15:45
[Sub Story]
´ç´¢º´ ȯÀÚ Ç÷¾ÐÄ¡·á·Î ½ÅÀåÁúȯ À§Çè±îÁö
ÀÌ»óµ· ±âÀÚ
2021-04-16 11:55
[Conference Report]
ÇǸ¶»ç¸£Åº ¡®´Ü¹é´¢ °¨¼Ò¡¯ ÀûÀÀÁõ È®´ë ½ÉÇ÷°ü¡¤½ÅÀ庸ȣȿ°ú Á¤Á¶ÁØ
ÀÌ»óµ· ±âÀÚ
2021-04-16 11:50
[Sub Story]
LDL-C ¸ñǥġ ³»·Á°¡´Ï ºñ½ºÅ¸Æ¾°è º´¿ëÀº Up
ÀÌ»óµ· ±âÀÚ
2021-03-09 13:47
¶óÀÎ
[Sub Story]
Ç÷´ç°ÇÏÁ¦ÀÇ ½ÉÇ÷°ü ÇýÅÃÀº?
ÀÌ»óµ· ±âÀÚ
2021-03-09 10:45
[Sub Story]
1Â÷Ä¡·á¿¡ »ýÈ°¿ä¹ý°ú Ç÷´ç°ÇÏÁ¦
ÀÌ»óµ· ±âÀÚ
2021-02-02 10:21
[Sub Story]
Ç÷´ç°ÇÏÁ¦ ¼±Åýà °í·Á»çÇ×
ÀÌ»óµ· ±âÀÚ
2021-02-02 10:21
[Cover Story]
¡®2021¡¯ ADA °¡À̵å¶óÀÎ º¸¸é
¡®ÀÌ°øÀÌÀÏ¡¯ ´ç´¢º´ °ü¸®¹æÇâ º¸ÀδÙ
ÀÌ»óµ· ±âÀÚ
2021-02-01 18:26
[Sub Story]
CKD ȯÀÚ ½ÉÇ÷°ü À§Çè °ü¸®¿¡µµ SGLT-2I¡¤GLP-1RA ±Ç°í
ÀÓ¼¼Çü ±âÀÚ
2021-02-01 15:40
¶óÀÎ
[Sub Story]
¿¥Æı۸®Ç÷ÎÁø ¡®½ÉºÎÀü¡¤½ÅÀåÁúȯ¡¯ ¾à¹°·Î ÀÚ¸®¸Å±è
ÀÓ¼¼Çü ±âÀÚ
2021-02-01 15:39
[Sub Story]
SGLT-2¾ïÁ¦Á¦ÀÇ ¾àÁø...
ASCVD¿¡ À̾î HF¡¤CKD±îÁö
ÀÌ»óµ· ±âÀÚ
2021-01-04 17:44
[Conference Report]
´ÙÆı۸®Ç÷ÎÁø ¡®½ÅÀå¾à¡¯À¸·Î ÇÕ°ÝÁ¡
THE MOST
2020-10-12 15:58
[Conference Report]
½ÅÀ庸ȣ SGLT-2¾ïÁ¦Á¦ Ç÷¾Ð°ÇÏ È¿°ú ´õÇÏ´Ù
ÀÌ»óµ· ±âÀÚ
2020-09-29 11:06
[Sub Story]
1Â÷Ä¡·á ´ëü¿ª·® UP
ÀÌ»óµ· ±âÀÚ
2020-07-26 19:25
-
1
2
3
4
5
6
-
¿©¹é
Sub
news
¡°ACEI ÀÓ»ó±Ù°Å ³õ°í, ȯÀÚ ¼³µæÇÏÀÚ¡±
Q. Ç÷¾Ð°ÇÏ Ãø¸é¿¡¼ ACEIÀÇ Æ¯¼ºÀº?ù...
¡°SGLT-2i Ȳ±Ý±â´Â TZD¿Í º´¿ëÀ¸·ÎºÎÅÍ¡±
Q. SGLT-2iÀÇ °è¿È¿°ú¿¡ ´ëÇÑ °ßÇØ´Â...
¡°°í°µµ ½ºÅ¸Æ¾ Á¦Á¦ È¿°ú ´ëµîÇϳª ¾ÈÀü¼º ´Ù¸¦ ¼öµµ¡±
Q. CAD ȯÀÚÀÇ ÀÌ»óÁöÁúÇ÷Áõ Ä¡·áÀü·«Àº?...
¿©¹é
¿©¹é
Back to Top